Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
967 participants
INTERVENTIONAL
2008-03-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors
NCT02996331
Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard Repositioning
NCT02690753
RESTART the Prevention of Pressure Ulcers: Comparing the Effectiveness and Cost of a Reactive Static Air Mattress and Alternating Air Pressure Mattress
NCT06294327
Skin Dressings Versus Lubrication to Prevent Pressure Ulcers: A Randomized Trial
NCT02565745
Pressure Sore Prevention Strategy for the Prone Position
NCT06442657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2. High Risk
High risk for pressure ulcers according to the Braden Scale for Predicting Pressure Sore Risk (Score 10-12)
Turning or repositioning schedule
Turning schedule randomly assigned at 2, 3 or 4 hours
1. Moderate Risk
Moderate risk for pressure ulcers according to the Braden Scale for Predicting Pressure Sore Risk (Score 13 and 14)
Turning or repositioning schedule
Turning schedule randomly assigned at 2, 3, or 4 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Turning or repositioning schedule
Turning schedule randomly assigned at 2, 3, or 4 hours
Turning or repositioning schedule
Turning schedule randomly assigned at 2, 3 or 4 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a Braden Scale Score between 10 - 12 (high risk) or 13 -14 (moderate risk) within one week of admission (new residents) or greater than 90 days (established residents) of study participation
* Have a high-density foam replacement mattress in use or can be transferred to such a mattress.
* Are 65 years or older. Younger residents are present in fewer numbers and may have different health issues and co-morbidities than older residents.
* Can legally grant consent to participate or have available surrogates to grant consent. If able, participant should assent when a surrogate grants consent.
* Expected to have a length of stay of 21 days or greater.
Exclusion Criteria
* The Braden Scale score is 15 or greater indicating mild risk or no risk, or 9 or below indicating very high risk.
* The resident cannot be turned on 3 anatomical surfaces (side, back, side) or has a contraindication to repositioning.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of Nursing Research (NINR)
NIH
National Institute on Aging (NIA)
NIH
Ontario Ministry of Health and Long Term Care
OTHER_GOV
Toronto Health Economic Technology Assessment collaborative (THETA)
UNKNOWN
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy Bergstrom
Trumble Professor of Aging Research & Director, Center on Aging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy Bergstrom, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Susan Horn, PhD
Role: PRINCIPAL_INVESTIGATOR
ISIS, Salt Lake City, UT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glencroft Care Center
Glendale, Arizona, United States
Linda Valley Nursing Facility
Loma Linda, California, United States
Garden Crest Convalescent Hospital
Los Angeles, California, United States
St. Catherine Laboure Manor
Jacksonville, Florida, United States
Miami Jewish Home & Hospital
Miami, Florida, United States
Palatka Health Care Center
Palatka, Florida, United States
Kindred Bremen Health Care Center
Bremen, Indiana, United States
Tower Hill Center for Health and Rehabilitation
Canton, Massachusetts, United States
Gurwin Jewish Nursing and Rehabilitation Center
Commack, New York, United States
Monroe Community Hospital
Rochester, New York, United States
BlumenthalJewish Nursing and Rehabilitation
Greensboro, North Carolina, United States
Hennis Care Center
Dover, Ohio, United States
Dorothy Love Retirement Community
Sidney, Ohio, United States
Fairmount at aBreckenridge Village
Willoughby, Ohio, United States
Park Vista Retirement Community
Youngstown, Ohio, United States
Signature HealthCare of Columbia
Columbia, Tennessee, United States
Kindred Loudon Healthcare Center
Loudon, Tennessee, United States
Kindred Fairpark Health Care Center
Maryville, Tennessee, United States
Asbury Place Maryville
Maryville, Tennessee, United States
Tyndall Nursing Home
East Missassauga, Ontario, Canada
Malton Village Long Term Care Center
Mississauga, Ontario, Canada
Specialty Care of Mississauga Road
Mississauga, Ontario, Canada
Yee Hong Scarborough
Scarborough Village, Ontario, Canada
Shepherd Lodge
Scarborough Village, Ontario, Canada
Leisure World Lawrence
Toronto, Ontario, Canada
Villa Leonardo Gambin Specialty Care
Woodbridge, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yap TL, Kennerly SM, Bergstrom N, Hudak SL, Horn SD. An Evidence-Based Cue-Selection Guide and Logic Model to Improve Pressure Ulcer Prevention in Long-term Care. J Nurs Care Qual. 2016 Jan-Mar;31(1):75-83. doi: 10.1097/NCQ.0000000000000128.
Omolayo T, Brown K, Rapp MP, Li J, Barrett R, Horn S, Bergstrom N. Construct validity of the moisture subscale of the Braden Scale for Predicting Pressure Sore Risk. Adv Skin Wound Care. 2013 Mar;26(3):122-7. doi: 10.1097/01.ASW.0000427921.74379.c5.
Related Links
Access external resources that provide additional context or updates about the study.
Home of the Braden Scale and source of official copies of the tool and the location for obtaining permission to use the tool.
Home of the National Pressure Ulcer Advisory Panel with information regarding staging and policies regarding pressure ulcers
Home page of the Wound Ostomy and Continence Nurses Organization, the experts in wound healing.
Hennis Care Center of Dover, Ohio is a data collection site
Gurwin Jewish Nursing and Rehabilitation Center, Commack, NY, is a data collection site
Monro Community Hospital, Rochester, NY, is a data collection sites
Specialty Care Mississauga Road, Mississauga, Ontario, Canada is a data collection site
Villa Leonardo Gambin, Woodbridge, Ontario, Canada is a data collection site
Fairmount at Breckenridge Village is a data collection site
St. Catherine Laboure Manor is a data collection site
Kindred Bremen Health Care Center
Miami Jewish Home \& Hospital will be a data collection site
Kindred Fairpark Health Care Center is a data collection site
Kindred Loudon Healthcare Center is a data collection site
Related Info
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1R011NR009680-01A1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.